Emerald Advisers’s Twist Bioscience TWST Stock Holding History

Emerald Advisers’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-42,678	Closed	-$5.29M	–	305
2021 Q1	$5.29M	Sell	42,678 -92,169	-68%	-$14M	0.19%	118
2020 Q4	$19.1M	Sell	134,847 -259,964	-66%	-$28.8M	0.63%	70
2020 Q3	$30M	Sell	394,811 -69,439	-15%	-$4.32M	1.23%	23
2020 Q2	$21M	Sell	464,250 -29,226	-6%	-$1.05M	0.92%	45
2020 Q1	$15.1M	Buy	493,476 +160,339	+48%	+$4.31M	0.87%	41
2019 Q4	$7M	Sell	333,137 -227,570	-41%	-$5.33M	0.3%	108
2019 Q3	$13.4M	Sell	560,707 -18,894	-3%	-$549K	0.63%	61
2019 Q2	$16.8M	Buy	579,601 +344,463	+146%	+$9.11M	0.68%	60
2019 Q1	$5.45M	Buy	235,138 +70,391	+43%	+$1.59M	0.22%	113
2018 Q4	$3.8M	Buy	+164,747	New	+$3.65M	0.19%	111

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Emerald Advisers's TWST Position: Q2 2021 in Review

Emerald Advisers sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 42,678 shares — an estimated $5.29M sold.

Emerald Advisers first reported a position in TWST in Q4 2018 and held it in 10 quarters. The position peaked at $30M in Q3 2020. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

Emerald Advisers reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
Emerald Advisers sold 42,678 Twist Bioscience shares in Q2 2021, an estimated $5.29M.
Emerald Advisers first reported a position in Twist Bioscience in Q4 2018 and held it in 10 quarters.
Emerald Advisers's Twist Bioscience position peaked at $30M in Q3 2020.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Emerald Advisers's 13F filing for Q2 2021, filed 29 Jul 2021.